{"transactions":[{"id":1191925,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81564,"kind":"person","name":"Levisetti Matteo","position":1,"cik":"0001962444","reported_name":"Levisetti Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-25T20:00:03.000Z","date":"2025-03-21","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025."}],"balance_after":250000,"derivative":{"exercise_price":0.99,"expiration_date":"2035-03-20","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-25-044343","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017025044343/ownership.xml","form_type":"4"}},{"id":1486110,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81564,"kind":"person","name":"Levisetti Matteo","position":1,"cik":"0001962444","reported_name":"Levisetti Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:00:11.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.65,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-070565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024070565/ownership.xml","form_type":"4"}},{"id":1585938,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81564,"kind":"person","name":"Levisetti Matteo","position":1,"cik":"0001962444","reported_name":"Levisetti Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-08T21:00:06.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option becomes exercisable in eight equal semi-annual installments beginning on September 6, 2024."}],"balance_after":260000,"derivative":{"exercise_price":1.94,"expiration_date":"2034-03-05","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0000950170-24-028608","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024028608/ownership.xml","form_type":"4"}},{"id":1624560,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81564,"kind":"person","name":"Levisetti Matteo","position":1,"cik":"0001962444","reported_name":"Levisetti Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T21:00:07.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 17, 2023 the Reporting Person was granted an option with vesting subject to the satisfaction of performance-based vesting criteria.  The performance-based vesting criteria was deemed satisfied or waived on February 20, 2024 and these shares underlying the option vested in full."}],"balance_after":25000,"derivative":{"exercise_price":3.36,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-018724","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000095017024018724/ownership.xml","form_type":"4"}},{"id":1823399,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81564,"kind":"person","name":"Levisetti Matteo","position":1,"cik":"0001962444","reported_name":"Levisetti Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-25T16:33:06.000Z","date":"2023-07-21","kind":"grant","planned":false,"acquired":true,"shares":82500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023."}],"balance_after":82500,"derivative":{"exercise_price":4.2,"expiration_date":"2033-07-20","underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001209191-23-043278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123043278/doc4.xml","form_type":"4"}},{"id":2050379,"issuer":{"id":6301,"kind":"organization","name":"Cue Biopharma, Inc.","symbol":"CUE"},"owners":[{"id":81564,"kind":"person","name":"Levisetti Matteo","position":1,"cik":"0001962444","reported_name":"Levisetti Matteo","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-19T21:02:38.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in eight equal semi-annual installments beginning on 7/17/2023"}],"balance_after":110000,"derivative":{"exercise_price":3.36,"expiration_date":"2033-01-16","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-23-003988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645460/000120919123003988/doc4.xml","form_type":"4"}}]}